French pharmaceutical giant invests at least $1.7 billion in Regeneron cancer drug

... be targeted at cancer cells, which is a hot field in drug development, the two companies announced Tuesday. The Tarrytown, New York-based Regeneron will get $640 million for the partnership upfront, and the two companies will equally split a $650 ...
http://ift.tt/1HYVR5a